Navigation Links
Fighting fire with fire: 'Vampire' bacteria has potential as living antibiotic
Date:10/31/2011

A vampire-like bacteria that leeches onto specific other bacteria including certain human pathogens has the potential to serve as a living antibiotic for a range of infectious diseases, a new study indicates.

The bacterium, Micavibrio aeruginosavorus, was discovered to inhabit wastewater nearly 30 years ago, but has not been extensively studied because it is difficult to culture and investigate using traditional microbiology techniques. However, biologists in the University of Virginia's College of Arts & Sciences, Martin Wu and graduate student Zhang Wang, have decoded its genome and are learning "how it makes its living," Wu said.

The bacterium "makes its living" by seeking out prey certain other bacteria and then attaching itself to its victim's cell wall and essentially sucking out nutrients. Unlike most other bacteria, which draw nutrients from their surroundings, M. aeruginosavorus can survive and propagate only by drawing its nutrition from specific prey bacteria. This kills the prey making it a potentially powerful agent for destroying pathogens.

One bacterium it targets is Pseudomonas aeruginosavorus, which is a chief cause of serious lung infections in cystic fibrosis patients.

"Pathologists may eventually be able to use this bacterium to fight fire with fire, so to speak, as a bacterium that will aggressively hunt for and attack certain other bacteria that are extremely harmful to humans," Wu said.

His study, detailing the DNA sequence of M. aeruginosavorus, is published online in the journal BMC Genomics [link: http://www.biomedcentral.com/1471-2164/12/453].It provides new insights to the predatory lifestyle of the bacterium and a better understanding of the evolution of bacterial predation in general.

"We used cutting-edge genomic technology in our lab to decode this bacterium's genome," Wu said. "We are particularly interested in the molecular mechanisms that allow it to hunt for and attack prey. This kind of investigation would have been extremely difficult and expensive to do only a few years ago."

He noted that overuse of traditional antibiotics, which work by either inhibiting bacteria propagation or interfering with cell wall formation, are creating so-called "super bugs" that have developed resistances to treatment strategies. He suggests that new approaches are needed for attacking pathogens without building up their resistance.

Additionally, because M. aeruginosavorus is so selective a feeder, it is harmless to the thousands of beneficial bacteria that dwell in the general environment and in the human body.

"It is possible that a living antibiotic such as M. aeruginosavorus because it so specifically targets certain pathogens could potentially reduce our dependence on traditional antibiotics and help mitigate the drug-resistance problem we are now facing," Wu said.

Another benefit of the bacterium is its ability to swim through viscous fluids, such as mucus. P. aeruginosavorus, the bacterium that colonizes the lungs of cystic fibrosis patients, creates a glue-like biofilm, enhancing its resistance to traditional antibiotics. Wu noted that the living cells of M. aeruginosavorus can swim through mucus and biofilm and attack P. aeruginosavorus.

M. aeruginosavorus also might have industrial uses, such as reducing bacteria that form biofilms in piping, and for medical devices, such as implants that are susceptible to the formation of biofilms.

Wu said M. aeruginosavorus requires further study for a more thorough understanding of its gene functions. He said genetic engineering would be required to tailor the predatory attributes of the bacterium to specific uses in the treatment of disease.

"We have a map now to work with, and we will see where it leads," he said.


'/>"/>
Contact: Fariss Samarrai
fls4f@virginia.edu
434-924-3778
University of Virginia
Source:Eurekalert

Related medicine news :

1. Fighting breast cancer early, one cell at a time
2. Fighting a smarter war against cancer
3. More evidence that allergies may help in fighting brain tumors
4. Stem cells, potential source of cancer-fighting T cells
5. Study linking gut microbe type with diet has implications for fighting GI disorders
6. Survivor Builds Cancer-Fighting House
7. Mouse Study Could Give New Clues to Fighting Baldness
8. Trial of Cancer-Fighting Virus Shows Promise
9. Rare immune cell is asset and liability in fighting infection
10. DOE laboratories help develop promising new cancer fighting drug, vemurafenib
11. Fighting breast cancer from new angles
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... Bill Howe started his sewer ... coastal communities. After Tina Howe joined the team, the Bill Howe brand was born ... at affordable rates, and giving back to the San Diego community in which they ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... conducting a pilot study of ActiGraph’s CentrePoint Data Hub in a ... leading provider of clinical-grade wearable activity and sleep monitoring solutions for the global ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... the Brooke Grove Foundation implement a Microsoft Dynamics GP solution that integrates to ... ERP expert that specializes in long-term care, Brooke Grove now has the capability ...
(Date:4/28/2017)... CA (PRWEB) , ... April 28, 2017 , ... NuevaCare, ... cities as diverse as Millbrae, Burlingame, and Palo Alto, is proud to announce information ... interested persons to bookmark and read organized content on topics such as home care ...
(Date:4/28/2017)... Rochester, NY (PRWEB) , ... April 28, 2017 ... ... is celebrating its 5th anniversary. SearchLight is the premier online modeling resource for ... “With more than 30,000 active users during last 5 years spanning the globe, ...
Breaking Medicine News(10 mins):
(Date:4/21/2017)... 21, 2017 Halo Labs announces the launch ... analysis system called the Horizon at PEGS 2017 in ... new system analyzes sub visible particulate matter in biopharmaceutical ... screening as early as candidate selection and pre-formulation. ... contract research organization Elion Labs for system ...
(Date:4/20/2017)... , April 20, 2017 ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production ... report to their offering. ... "Global Biosimilar Pipeline and Market Prospects: ... Design" provides an in-depth assessment of the current trends ...
(Date:4/20/2017)...   ZappRx, Inc ., a digital health company focused ... announced it closed $25 million in Series B funding led ... in Seattle that is part of ... Series B round included participation from SR One , ... GV (formerly Google Ventures). As part of the financing, ...
Breaking Medicine Technology: